These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 34591593

  • 41. Sex-biased molecular differences in lung adenocarcinoma are ethnic and smoking specific.
    Li X, Wei S, Deng L, Tao H, Liu M, Zhao Z, Du X, Li Y, Hou J.
    BMC Pulm Med; 2023 Mar 24; 23(1):99. PubMed ID: 36964522
    [Abstract] [Full Text] [Related]

  • 42. Genomic landscape of lung adenocarcinoma in East Asians.
    Chen J, Yang H, Teo ASM, Amer LB, Sherbaf FG, Tan CQ, Alvarez JJS, Lu B, Lim JQ, Takano A, Nahar R, Lee YY, Phua CZJ, Chua KP, Suteja L, Chen PJ, Chang MM, Koh TPT, Ong BH, Anantham D, Hsu AAL, Gogna A, Too CW, Aung ZW, Lee YF, Wang L, Lim TKH, Wilm A, Choi PS, Ng PY, Toh CK, Lim WT, Ma S, Lim B, Liu J, Tam WL, Skanderup AJ, Yeong JPS, Tan EH, Creasy CL, Tan DSW, Hillmer AM, Zhai W.
    Nat Genet; 2020 Feb 24; 52(2):177-186. PubMed ID: 32015526
    [Abstract] [Full Text] [Related]

  • 43. Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
    Byeon S, Lee B, Park WY, Choi YL, Jung HA, Sun JM, Ahn JS, Ahn MJ, Park K, Lee SH.
    Clin Lung Cancer; 2020 May 24; 21(3):e182-e190. PubMed ID: 31839532
    [Abstract] [Full Text] [Related]

  • 44. Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations.
    Park SJ, Ju S, Goh SH, Yoon BH, Park JL, Kim JH, Lee S, Lee SJ, Kwon Y, Lee W, Park KC, Lee GK, Park SY, Kim S, Kim SY, Han JY, Lee C.
    Cancer Res; 2024 May 02; 84(9):1491-1503. PubMed ID: 38607364
    [Abstract] [Full Text] [Related]

  • 45. Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
    Soo RA, Kubo A, Ando M, Kawaguchi T, Ahn MJ, Ou SI.
    Clin Lung Cancer; 2017 Sep 02; 18(5):535-542. PubMed ID: 28433570
    [Abstract] [Full Text] [Related]

  • 46. Risk of lung adenocarcinoma from smoking and radiation arises in distinct molecular pathways.
    Castelletti N, Kaiser JC, Simonetto C, Furukawa K, Küchenhoff H, Stathopoulos GT.
    Carcinogenesis; 2019 Oct 16; 40(10):1240-1250. PubMed ID: 30915466
    [Abstract] [Full Text] [Related]

  • 47. Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing.
    Kim HS, Cha H, Kim J, Park WY, Choi YL, Sun JM, Ahn JS, Ahn MJ, Park K, Lee SH.
    Eur J Cancer; 2019 Oct 16; 120():65-74. PubMed ID: 31493723
    [Abstract] [Full Text] [Related]

  • 48. Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq.
    Beane J, Vick J, Schembri F, Anderlind C, Gower A, Campbell J, Luo L, Zhang XH, Xiao J, Alekseyev YO, Wang S, Levy S, Massion PP, Lenburg M, Spira A.
    Cancer Prev Res (Phila); 2011 Jun 16; 4(6):803-17. PubMed ID: 21636547
    [Abstract] [Full Text] [Related]

  • 49. Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling.
    Testa U, Pelosi E, Castelli G.
    Expert Rev Mol Diagn; 2022 Jan 16; 22(1):77-100. PubMed ID: 34894979
    [Abstract] [Full Text] [Related]

  • 50. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
    Drilon A, Wang L, Arcila ME, Balasubramanian S, Greenbowe JR, Ross JS, Stephens P, Lipson D, Miller VA, Kris MG, Ladanyi M, Rizvi NA.
    Clin Cancer Res; 2015 Aug 15; 21(16):3631-9. PubMed ID: 25567908
    [Abstract] [Full Text] [Related]

  • 51. Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing.
    Li D, Huang Y, Cai L, Wu M, Bao H, Xu Y, Wei Y, Wu S, Wu X, Shao Y, Zhao W, Lv G, Huang S, Zhang T, Shi Y.
    Neoplasia; 2021 Dec 15; 23(12):1204-1212. PubMed ID: 34735995
    [Abstract] [Full Text] [Related]

  • 52. Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome.
    Grosse C, Soltermann A, Rechsteiner M, Grosse A.
    PLoS One; 2019 Dec 15; 14(8):e0220691. PubMed ID: 31386689
    [Abstract] [Full Text] [Related]

  • 53. Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations.
    Gazdar A, Robinson L, Oliver D, Xing C, Travis WD, Soh J, Toyooka S, Watumull L, Xie Y, Kernstine K, Schiller JH.
    J Thorac Oncol; 2014 Apr 15; 9(4):456-63. PubMed ID: 24736066
    [Abstract] [Full Text] [Related]

  • 54. Republished: lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?
    Ou SH.
    Postgrad Med J; 2014 Apr 15; 90(1062):228-35. PubMed ID: 24643262
    [Abstract] [Full Text] [Related]

  • 55. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
    Shi J, Hua X, Zhu B, Ravichandran S, Wang M, Nguyen C, Brodie SA, Palleschi A, Alloisio M, Pariscenti G, Jones K, Zhou W, Bouk AJ, Boland J, Hicks B, Risch A, Bennett H, Luke BT, Song L, Duan J, Liu P, Kohno T, Chen Q, Meerzaman D, Marconett C, Laird-Offringa I, Mills I, Caporaso NE, Gail MH, Pesatori AC, Consonni D, Bertazzi PA, Chanock SJ, Landi MT.
    PLoS Med; 2016 Dec 15; 13(12):e1002162. PubMed ID: 27923066
    [Abstract] [Full Text] [Related]

  • 56. Identification immunophenotyping of lung adenocarcinomas based on the tumor microenvironment.
    Tan Q, Huang Y, Deng K, Lu M, Wang L, Rong Z, Zhao W, Li S, Xu Z, Fan L, Li K, Li Z.
    J Cell Biochem; 2020 Nov 15; 121(11):4569-4579. PubMed ID: 32030808
    [Abstract] [Full Text] [Related]

  • 57. Genetic Alterations in Preinvasive Lung Synchronous Lesions.
    Ahn S, Lim J, Park SY, Kim H, Kwon HJ, Han YB, Lee CT, Cho S, Chung JH.
    Cancer Res Treat; 2020 Oct 15; 52(4):1120-1134. PubMed ID: 32599981
    [Abstract] [Full Text] [Related]

  • 58. Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation.
    Dasgupta S, Soudry E, Mukhopadhyay N, Shao C, Yee J, Lam S, Lam W, Zhang W, Gazdar AF, Fisher PB, Sidransky D.
    J Cell Physiol; 2012 Jun 15; 227(6):2451-60. PubMed ID: 21830212
    [Abstract] [Full Text] [Related]

  • 59. Differential expression of lung adenocarcinoma transcriptome with signature of tobacco exposure.
    Hammouz RY, Kostanek JK, Dudzisz A, Witas P, Orzechowska M, Bednarek AK.
    J Appl Genet; 2020 Sep 15; 61(3):421-437. PubMed ID: 32564237
    [Abstract] [Full Text] [Related]

  • 60. Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas.
    Sands JM, Nguyen T, Shivdasani P, Sacher AG, Cheng ML, Alden RS, Jänne PA, Kuo FC, Oxnard GR, Sholl LM.
    Lung Cancer; 2020 Feb 15; 140():35-41. PubMed ID: 31855703
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.